CD38 and Miyoshi myopathy: To explore the anti-MM activities of these CAR-Ts, three MM cell lines, MM.1 s, U266 and RPMI-8226, with heterogeneous BCMA and CD38 expression were used (Additional file 1: Fig. S2).